Log in

Relevant bibliographies by topics / Retinal vein thrombosis / Journal articles

To see the other types of publications on this topic, follow the link: Retinal vein thrombosis.

Journal articles on the topic 'Retinal vein thrombosis'

Author: Grafiati

Published: 28 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Retinal vein thrombosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Maksymuk, O. Ju. "OPTICAL COHERENT TOMOGRAPHY IN DIAGNOSIS OF ACUTE DISORDERS OF VENOUS BLOOD CIRCULATION IN THE RETINA AND THEIR COMPLICATIONS." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 20, no. 4 (2020): 72–77. http://dx.doi.org/10.31718/2077-1096.20.4.72.

Full text

Abstract:

A comprehensive ophthalmological examination of patients with acute disorders of venous blood circulation in the retina was carried out using a new, modern, non-contact and highly accurate method of diagnosing ophthalmological diseases – optical coherent tomography. The features of optical coherent tomography in patients with different types of acute disorders of venous blood circulation in the retina are described. Comprehensive examination of such patients using traditional ophthalmological methods, biomicroophthalmoscopy, retinal photography using a fundus camera, fluorescent angiogra

APA, Harvard, Vancouver, ISO, and other styles

2

Krylova, A. A. "Features and patterns of the course of photoinduced retinal veins thrombosis in the experiment." Modern technologies in ophtalmology, no. 1 (March 28, 2023): 77–83. http://dx.doi.org/10.25276/2312-4911-2023-1-77-83.

Full text

Abstract:

Central retinal vein occlusion (CRVO) was first described in the 19th century, but some aspects of the pathogenesis of the disease remain controversial to this day [1]. In the development of retinal vein obturation hemorheological, coagulation, hemodynamic and immune-inflammatory factors are important [2, 3]. Creation of an experimental model of CRVO and its branches (BRVO) as close as possible to the natural course of the disease, will provide new knowledge about the pathogenesis of retinal vein obturation, which may help in the development of a new method for treating this pathology. Purpose

APA, Harvard, Vancouver, ISO, and other styles

3

Skajaa, Nils, Erzsébet Horváth-Puhó, Kasper Adelborg, Paolo Prandoni, Kenneth J. Rothman, and Henrik Toft Sørensen. "Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality." TH Open 03, no. 02 (2019): e171-e179. http://dx.doi.org/10.1055/s-0039-1692399.

Full text

Abstract:

Background Many cardiovascular conditions exhibit seasonality in occurrence and mortality, but little is known about the seasonality of venous thromboembolism. Methods Using Danish registries, we identified all patients with deep vein thrombosis, pulmonary embolism, splanchnic vein thrombosis, cerebral vein thrombosis, and retinal vein thrombosis during 1977–2016. We tallied monthly deaths occurring within 90 days of the venous thromboembolism diagnosis. We estimated peak-to-trough ratios and timing of the peak of both diagnoses and deaths summed over all years of the study period. The departu

APA, Harvard, Vancouver, ISO, and other styles

4

Lee, Hansang, Chul Hee Lee, Eun Young Choi, Junwon Lee, and Min Kim. "Deep Vein Thrombosis Following Prolonged Prone Position Maintenance after Vitrectomy for Rhegmatogenous Retinal Detachment." Journal of the Korean Ophthalmological Society 64, no. 4 (2023): 355–58. http://dx.doi.org/10.3341/jkos.2023.64.4.355.

Full text

Abstract:

Purpose: We report a rare case of deep vein thrombosis and pulmonary embolism that occurred following 2 weeks in the prone position after a trans pars plana vitrectomy with gas tamponade to treat rhegmatogenous retinal detachment.Case Summary: A 49-year-old man without a remarkable medical history visited our clinic complaining of gradual vision loss on the inferior side of the left eye. In fundus examinations, rhegmatogenous retinal detachment involving the macula with multiple tears was noted. After trans pars plana vitrectomy with gas tamponade, the patient was encouraged to maintain a pron

APA, Harvard, Vancouver, ISO, and other styles

5

Ageno, Walter. "Treatment of Atypical Clots." Hämostaseologie 42, no. 01 (2022): 010–18. http://dx.doi.org/10.1055/a-1669-3336.

Full text

Abstract:

AbstractThe term unusual site thrombosis refers to the occurrence of venous thromboembolism outside of the lower limbs and the pulmonary arteries. Unusual site thrombosis can virtually affect any venous segment, with the most common and/or clinically relevant sites including the upper limbs veins, the retinal veins, the splanchnic veins and the cerebral veins. Clinical features are obviously heterogeneous, while many predisposing factors are common, though with different prevalence among the various disorders. Antithrombotic therapy is prescribed to most patients, but the type, intensity, and

APA, Harvard, Vancouver, ISO, and other styles

6

Razmeh, Saeed, Nafiseh Niknam, Negar Sadat Rabbani, Shekoofeh Nikoee, Fatemeh Vafa Pour, and Laleh Taghavian. "Cortical Vein Thrombosis after Infliximab Treatment for Crohn’s Disease." Neurology International 13, no. 1 (2021): 120–24. http://dx.doi.org/10.3390/neurolint13010011.

Full text

Abstract:

Inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s disease puts patients at high risk of thromboembolism accidents. These patients may take infliximab for active and fistulating Crohn’s disease, which can also increase the risk of thrombosis. Deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) are more common among these patients, but cerebrovascular, mesenteric, portal and retinal veins can also be affected. In this paper, we report a case of isolated right Labbe vein thrombosis after infliximab therapy for Crohn’s disease. To the best of our knowledge, our p

APA, Harvard, Vancouver, ISO, and other styles

7

Stuleva, N. S., A. V. Vorobiev, and E. A. Orudzhova. "A case of mesenteric vein thrombosis developed in the first trimester of pregnancy after in vitro fertilization and embryo transfer in a patient with antiphospholipid syndrome." Obstetrics, Gynecology and Reproduction 12, no. 4 (2019): 72–78. http://dx.doi.org/10.17749/2313-7347.2018.12.4.072-078.

Full text

Abstract:

Combined thrombophilia is known as a probable cause of recurrent in vitro fertilization (IVF) failures. The present clinical case demonstrates the importance of considering the possibility of inherited or acquired thrombophilia in patients under the preparation for IVF. Thromboses of rare locations (hepatic vein, splenic vein, mesenteric vein, ovarian vein, retinal vein, cerebral vein, portal vein, axillary and subclavian vein) are life-threatening conditions. Most often thrombosis of atypical location develops in patients with inherited hemostatic defects, e.g. genetic thrombophilia. Such thr

APA, Harvard, Vancouver, ISO, and other styles

8

LAKE, S. R., and S. A. VERNON. "Emergency contraception and retinal vein thrombosis." British Journal of Ophthalmology 83, no. 5 (1999): 628d. http://dx.doi.org/10.1136/bjo.83.5.628d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

REHAK, M., and P. WIEDEMANN. "Retinal vein thrombosis: pathogenesis and management." Journal of Thrombosis and Haemostasis 8, no. 9 (2010): 1886–94. http://dx.doi.org/10.1111/j.1538-7836.2010.03909.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Denis Solomons, Hilary. "Acute Megakaryoblastic Leukaemia and Retinal Vein Thrombosis." Cancer Research and Cellular Therapeutics 8, no. 7 (2024): 01–03. https://doi.org/10.31579/2640-1053/216.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Pola, P., P. Tondi, A. Favuzzi, et al. "Treatment of retinal vein thrombosis with defibrotide." Current Therapeutic Research 53, no. 3 (1993): 340–46. http://dx.doi.org/10.1016/s0011-393x(05)80793-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Hansen, Lene, Hanne Lene Kristensen, Toke Bek, and Jorgen Ingerslev. "Markers of thrombophilia in retinal vein thrombosis." Acta Ophthalmologica Scandinavica 78, no. 5 (2000): 523–26. http://dx.doi.org/10.1034/j.1600-0420.2000.078005523.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kabardina, Ekaterina V., and Irina P. Shurygina. "CONTEMPORARY VIEW OF RETINAL VEIN THROMBOSES." Kuban Scientific Medical Bulletin 26, no. 1 (2019): 187–95. http://dx.doi.org/10.25207/1608-6228-2019-26-1-187-195.

Full text

Abstract:

The aimof this work was to elucidate the modern concept of retinal vein thrombosis.In the literature review, the retinal vein thrombosis is considered as a disease with a variety of clinical forms, course types, complications and frequently an unfavourable prognosis in terms of the preservation of visual functions. There is a clear connection between eye vascular pathologies, somatic diseases and cerebrovascular pathologies.Conclusion.The analysis of scientific sources has shown that many aspects of retinal ischemia are yet to be understood. Of particular importance is the development of effec

APA, Harvard, Vancouver, ISO, and other styles

14

Vayalambrone, Deepak, Tsveta Ivanova, and Aseema Misra. "Nonischemic Central Retinal Vein Occlusion in an Adolescent Patient with Ulcerative Colitis." Case Reports in Ophthalmological Medicine 2011 (2011): 1–2. http://dx.doi.org/10.1155/2011/963583.

Full text

Abstract:

Inflammatory bowel disease (IBD) can present with extraintestinal manifestations occasionally involving the eye. Retinal vein occlusions are rarely seen and have never been reported in the pediatric population though vascular thrombosis can be associated with IBD. Here, we present a case of what we believe is the youngest reported patient with nonischemic central retinal vein occlusion (CRVO).

APA, Harvard, Vancouver, ISO, and other styles

15

Shchuko, A. G., V. V. Bukina, A. S. Grishchuk та T. N. Iureva. "Interdisciplinary approach in the diagnosis and treatment of macular edema caused by thrombosis оf the central retinal vein or its branches". Modern technologies in ophtalmology, № 1 (28 березня 2023): 428–36. http://dx.doi.org/10.25276/2312-4911-2023-1-428-436.

Full text

Abstract:

Purpose. To present clinical cases of macular edema associated with central retinal vein thrombosis (CRVT) of various etiologies. Material and methods. A prospective study of patients with macular edema associated with thrombosis of the central retinal vein or its branches in real clinical practice was conducted. All patients underwent a standard ophthalmological examination, as well as optical coherence tomography (OCT), and a biochemical blood test was performed on a patient with suspected macroglobulinemia. Results. In the first clinical case, macular edema was associated with retinovasculi

APA, Harvard, Vancouver, ISO, and other styles

16

Pierre-Filho, Paulo de Tarso Ponte, Alessandra Maria Mont'Alverne Pierre, Maurício Abujamra Nascimento, and Ana Maria Marcondes. "Central retinal vein prethrombosis as an initial manifestation of protein S deficiency." Sao Paulo Medical Journal 122, no. 3 (2004): 134–35. http://dx.doi.org/10.1590/s1516-31802004000300012.

Full text

Abstract:

CONTEXT: Retinal vein thrombosis is most common in old people, and is often associated with systemic vascular disease. One of its rare systemic causes is protein S deficiency. CASE REPORT: A case of a 21-year-old woman with retinal vein prethrombosis associated only with protein S deficiency is described. She presented with acutely reduced visual acuity and a central scotoma in her left eye. Warfarin therapy was initiated, and complete improvement in ophthalmoscopic findings was subsequently observed. This case illustrates that protein S deficiency is a factor that should be considered in case

APA, Harvard, Vancouver, ISO, and other styles

17

Asaoka, Izuru, Setsuko Igarashi, Takeo Sato, and Shigeki Takahashi. "Experimental Branch Retinal Vein Obstruction by Photochemical Thrombosis." Japanese Heart Journal 31, no. 4 (1990): 574. http://dx.doi.org/10.1536/ihj.31.574.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

GREAVES, M. "Aging and the pathogenesis of retinal vein thrombosis." British Journal of Ophthalmology 81, no. 10 (1997): 810–11. http://dx.doi.org/10.1136/bjo.81.10.810.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

AGENO, W., A. SQUIZZATO, and A. LAZO-LANGNER. "Retinal vein thrombosis: pathogenesis and management: a rebuttal." Journal of Thrombosis and Haemostasis 9, no. 2 (2011): 418–19. http://dx.doi.org/10.1111/j.1538-7836.2010.04128.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Abu El-Asrar, A. M., A. Kareem Al-Momen, S. A. Alamro, A. G. M. Abdel Gader, and K. F. Tabbara. "Bilateral central retinal vein thrombosis in Behçet's disease." Clinical Rheumatology 15, no. 5 (1996): 511–13. http://dx.doi.org/10.1007/bf02229654.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Pardanani, Animesh, Terra L. Lasho, Kebede Hussein, et al. "JAK2V617F Mutation Screening as Part of the Hypercoagulable Workup in the Absence of Splanchnic Vein Thrombosis: Assessment of Value in a Series of 664 Consecutive Patients." Blood 110, no. 11 (2007): 3191. http://dx.doi.org/10.1182/blood.v110.11.3191.3191.

Full text

Abstract:

Abstract Background: JAK2V617F is a recurring mutation in patients with polycythemia vera (PV) (95%) and essential thrombocythemia (ET) (50%), diseases that are frequently complicated by arterial and/or venous thrombosis. JAK2V617F is also frequently identified in patients with splanchnic vein thrombosis, including in those with occult myeloproliferative disorder (MPD). We previously reported a low prevalence of JAK2V617F in thrombosis patients - only 2% of 210 patients with non-splanchnic vein thrombosis (Leukemia, 2007 Aug;21(8):1828–9), and <1% of 136 patients with arterial stroke (J Thr

APA, Harvard, Vancouver, ISO, and other styles

22

Shamray, V. S., N. V. Filina, and O. N. Kiseleva. "Laser surgery in the management of patients with retinal vein occlusion." Pacific Medical Journal, no. 3 (September 7, 2022): 10–12. http://dx.doi.org/10.34215/1609-1175-2022-3-10-12.

Full text

Abstract:

This literature review investigates issues associated with the use of laser surgery for preventing visual impairment in patients with retinal vein occlusion. To this end, we analyze publications on the place of laser surgery in the treatment of patients with occlusion of the central retinal vein or its branches, describing the existing spectrum of laser interventions and indications to their implementation in a particular clinical situation. The mechanism triggering retinal vein occlusion was shown to be most frequently thrombosis at the arteriovenous crossing and in area of the lamina cribros

APA, Harvard, Vancouver, ISO, and other styles

23

Salim, Sarwat, Wai-Ching Lam, and Wahid Hanna. "Central Retinal Vein Occlusion with Therapeutic Level of Anticoagulation." Case Reports in Medicine 2009 (2009): 1–2. http://dx.doi.org/10.1155/2009/827982.

Full text

Abstract:

Purpose. To describe a patient with two episodes of deep venous thrombosis and factor V Leiden mutation who presented with central retinal vein occlusion (CRVO) despite prophylactic use of warfarin sodium (Coumadin).Methods. A case report of a 44-year-old woman with a history of recurrent deep venous thrombosis and Factor V Leiden mutation was placed on lifelong prophylactic therapy with warfarin. The patient presented with CRVO in the left eye despite therapeutic levels of warfarin.Results. Extensive systemic evaluation disclosed high titers for antinuclear antibody (ANA).Conclusion. Systemic

APA, Harvard, Vancouver, ISO, and other styles

24

Leung, A. C. T., A. McLay, and J. M. Boulton-Jones. "Polyarteritis Presenting with Thrombocytosis and Central Retinal Vein Thrombosis." Scottish Medical Journal 32, no. 1 (1987): 24–26. http://dx.doi.org/10.1177/003693308703200112.

Full text

Abstract:

We report a case of polyarteritis in a 54 year old woman who presented with marked thrombocytosis and acute blindness in one eye secondary to central retinal vein thrombosis. She also developed bilateral pulmonary infiltrates and renal failure. The diagnosis was confirmed by histological changes in the renal biopsy. Treatment with immunosuppresives, plasma exchange and antiplatelet drugs led to rapid clinical improvement and recovery of renal function and prevented further thromboembolic episodes. Plasma exchange and antiplatelet drugs should be considered in polyarteritis group of systemic va

APA, Harvard, Vancouver, ISO, and other styles

25

Prisco, Domenico, and Rossella Marcucci. "Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach." Pathophysiology of Haemostasis and Thrombosis 32, no. 5-6 (2002): 308–11. http://dx.doi.org/10.1159/000073587.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Cacciapuoti, Federico. "Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states." Italian Journal of Medicine 14, no. 3 (2020): 136–42. http://dx.doi.org/10.4081/itjm.2020.1296.

Full text

Abstract:

Thrombophilia or hypercoagulable state is a predisposition to form clots. Thrombophilia can be inherited or acquired, and prevalently involves venous vessels. Inherited thrombophilia consists of congenital conditions, as methylenetetrahydrofolate reductase polymorphism, Factor V Leiden and prothrombin gene mutations, natural anticoagulant deficiencies, high level of factor VIII, or dysfibrinogenemia. These congenital disorders can be responsible for venous thromboembolism, particularly deep venous thrombosis, pulmonary embolism, and, less frequently, mesenteric veins thrombosis, kidneys’ veins

APA, Harvard, Vancouver, ISO, and other styles

27

Krylova, A. A., and O. I. Krivosheina. "Antiangiogenic therapy in combination with enzymatic thrombolysis – a new promising method for the treatment of retinal veins occlusion." Reflection, no. 1 (September 20, 2023): 54–57. http://dx.doi.org/10.25276/2686-6986-2023-1-54-57.

Full text

Abstract:

Сentral retinal vein occlusion (CRVO), the first mention of which was made more than 200 years ago, today is characterized by a sufficiently fully and in detail studied pathogenesis and a detailed clinical picture [1]. It should be noted that currently, when studying certain aspects of the pathogenesis of this disease, preference is given to studying the role of various angiogenic factors, in particular, vascular endothelial growth factor (VEGF) [2, 3]. At the same time, the assessment of the influence of coagulation, hemodynamic and immune-inflammatory factors of retinal vein occlusion to a c

APA, Harvard, Vancouver, ISO, and other styles

28

Rosendaal, F. R. "Risk Factors for Venous Thrombotic Disease." Thrombosis and Haemostasis 82, no. 08 (1999): 610–19. http://dx.doi.org/10.1055/s-0037-1615887.

Full text

Abstract:

IntroductionVenous thrombosis occurs in about 1 per 1,000 individuals per year.1,2 It usually affects the deep veins of the leg, but may occur in other sites, such as the upper extremities, cerebral sinus, liver and portal veins, or retinal veins. It also may occur in the superficial veins, usually in the leg. The predilection of thrombosis occurring in the leg is the result of the upright position of man, with the resulting slow antigravitational flow of blood in the veins of the leg. Embolization occurs when parts of the clot dislodge and are transported by the blood flow, usually through th

APA, Harvard, Vancouver, ISO, and other styles

29

Girtovitis, Fotios I., Elisabet Tsakiroglou, Michael D. Diamantidis, et al. "Thrombophilia as a Risk Factor for Central Retinal Vein Thrombosis." Blood 114, no. 22 (2009): 5054. http://dx.doi.org/10.1182/blood.v114.22.5054.5054.

Full text

Abstract:

Abstract Abstract 5054 Introduction An increased risk of central retinal vein occlusion in patients with hypertension, hypercholesterolemia and diabetes mellitus has been recently shown. However, controversial literature results have failed to establish an association between central retinal vein occlusion and thrombophilic abnormalities. Aim To investigate thrombophilic factors in patients with central retinal vein thrombosis. Material and Methods 20 patients with a median age of 48±13 yrs [7 males (median age 53,2±8,4 yrs) and 13 females (median age 48,1±17,7 yrs)], who presented in the Hemo

APA, Harvard, Vancouver, ISO, and other styles

30

Oto, S., H. Kart, S. Kadayifçilar, N. Özdemir, and P. Aydin. "Retinal Vein Occlusion in a Woman with Heterozygous Fabry's Disease." European Journal of Ophthalmology 8, no. 4 (1998): 265–67. http://dx.doi.org/10.1177/112067219800800412.

Full text

Abstract:

Fabry's disease is associated with high incidence of thrombosis in hemizygous males and heterozygous females. We describe a woman with Fabry's disease who developed hemi-central retinal vein occlusion during the follow-up. The vein occlusion showed a fulminant course ending with a painful blind eye within a short period. Fabry's disease should be considered in the differential diagnosis of the vascular occlusive disorders especially in young patients.

APA, Harvard, Vancouver, ISO, and other styles

31

Riva, N., F. Dentali, M. P. Donadini, A. Squizzato, and W. Ageno. "Risk of recurrence of unusual site venous thromboembolism." Hämostaseologie 33, no. 03 (2013): 225–31. http://dx.doi.org/10.5482/hamo-13-03-0006.

Full text

Abstract:

SummaryThe term unusual site venous thrombosis defines uncommon clinical manifestations of venous thromboembolism occurring in sites different from the lower limbs or the lungs, with peculiar pathophysiological features and clinical history. Information on long-term outcomes of unusual site thrombosis is generally scant, because most studies are small and usually retrospective.Recurrence rate of cerebral vein thrombosis is about 2/100 patient-years; the only identified predisposing factors have been male gender and personal history of thrombosis. Retinal vein occlusion showed a recurrence in t

APA, Harvard, Vancouver, ISO, and other styles

32

Lendzioszek, Maja, Anna Bryl, Ewa Poppe, Katarzyna Zorena, and Malgorzata Mrugacz. "Retinal Vein Occlusion–Background Knowledge and Foreground Knowledge Prospects—A Review." Journal of Clinical Medicine 13, no. 13 (2024): 3950. http://dx.doi.org/10.3390/jcm13133950.

Full text

Abstract:

Thrombosis of retinal veins is one of the most common retinal vascular diseases that may lead to vascular blindness. The latest epidemiological data leave no illusions that the burden on the healthcare system, as impacted by patients with this diagnosis, will increase worldwide. This obliges scientists to search for new therapeutic and diagnostic options. In the 21st century, there has been tremendous progress in retinal imaging techniques, which has facilitated a better understanding of the mechanisms related to the development of retinal vein occlusion (RVO) and its complications, and conseq

APA, Harvard, Vancouver, ISO, and other styles

33

Lipatkina, T. E., Е. V. Karlova, and A. V. Zolotarev. "Problems of treatment of primary openangle glaucoma in combination with thrombosis of the central retinal vein." GlaucomaNews, no. 1 (January 20, 2020): 65–69. http://dx.doi.org/10.25276/2227-8281-1-65-69.

Full text

Abstract:

Patients with primary open-angle glaucoma (POAG) and ophthalmic hypertension have an increased likelihood of developing occlusions (thrombosis) of the central retinal vein. Different groups of antihypertensive drugs differ in their mechanism of action and may affect concomitant ocular pathology, in particular, retinal edema, which occurs, for example, in occlusion of the central retinal vein. Used in most patients with glaucoma, prostaglandin analogs can contribute to the long-term preservation of macular edema due to the effect on the permeability of the vascular wall. Preparations of other p

APA, Harvard, Vancouver, ISO, and other styles

34

Sundaram, PShanmuga, and S. Padma. "Hughes syndrome with cerebral, skeletal infarction & retinal vein thrombosis." Indian Journal of Medical Research 141, no. 2 (2015): 249. http://dx.doi.org/10.4103/0971-5916.155600.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

REHAK, M., and P. WIEDEMANN. "Retinal vein thrombosis: pathogenesis and management: reply to a rebuttal." Journal of Thrombosis and Haemostasis 9, no. 2 (2011): 419–20. http://dx.doi.org/10.1111/j.1538-7836.2010.04145.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Buchman, Alan L., Anna Marie Babbo, and Richard G. Gieser. "Central Retinal Vein Thrombosis in a Patient with Ulcerative Colitis." Digestive Diseases and Sciences 51, no. 10 (2006): 1847–49. http://dx.doi.org/10.1007/s10620-006-9188-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Puli, Srinivas R., and David D. Benage. "Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease." American Journal of Gastroenterology 98, no. 4 (2003): 939–40. http://dx.doi.org/10.1111/j.1572-0241.2003.07368.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Tache, Jason Eli, Sramila Aithal, Allan Novetsky, Yi-Wu Huang, Norman Saffra, and Harry Marshak. "Retinal Vein Thrombosis as the Presenting Symptom of Essential Thrombocythemia." American Journal of the Medical Sciences 329, no. 3 (2005): 139–40. http://dx.doi.org/10.1097/00000441-200503000-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Fruschelli, M., M. Capozzoli, C. Scapellato, P. Calzoni, and L. Puccetti. "New generation analysis of thrombin generation in retinal vein thrombosis." Acta Ophthalmologica 93 (September 23, 2015): n/a. http://dx.doi.org/10.1111/j.1755-3768.2015.0496.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Fruschelli, M., M. Capozzoli, C. Scapellato, P. Calzoni, and L. Puccetti. "New generation analysis of thrombin generation in retinal vein thrombosis." Acta Ophthalmologica 93 (September 23, 2015): n/a. http://dx.doi.org/10.1111/j.1755-3768.2015.1496.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Masoodi, I., I. A. Wani, S. Hussain, et al. "Sudden retinal vein thrombosis in a patient with nephrotic syndrome." Case Reports 2011, mar09 1 (2011): bcr1220103585. http://dx.doi.org/10.1136/bcr.12.2010.3585.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Gamidov, A. A., Z. V. Surnina, and I. V. Andreeva. "Management of patients with operated refractory neovascular glaucoma (clinical observation)." Meditsinskiy sovet = Medical Council, no. 12 (September 19, 2021): 374–78. http://dx.doi.org/10.21518/2079-701x-2021-12-374-378.

Full text

Abstract:

Introduction. Thrombosis (occlusion) of the central retinal vein (RCVO) and its branches is one of the main causes of loss or significant decrease in vision, including in people of working age, while RCVO is the second most common retinal vascular disease after diabetic retinopathy. The incidence rates steadily increase with age, amounting to 0.7% in the 49–60 age group and reaching 4.6% in people over 80 years old. Acute violation of retinal venous blood flow often leads to retinal ischemia, triggering the mechanism of activation of endothelial vascular growth factor (VEGF). In a quarter of p

APA, Harvard, Vancouver, ISO, and other styles

43

Franco-Moreno, Anabel, Elena Madroñal-Cerezo, Ana Martínez-Casa-Muñoz, Judith Ortiz-Sánchez, and Cristina Lucía Ancos-Aracil. "Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update." Pharmaceutics 17, no. 3 (2025): 342. https://doi.org/10.3390/pharmaceutics17030342.

Full text

Abstract:

Direct oral anticoagulants (DOACs) have emerged as the preferred oral anticoagulant therapy for patients with deep vein thrombosis of the lower extremities and pulmonary embolism. DOACs offer several advantages over vitamin K antagonists, including fixed dosage, fewer drug interactions, faster onset of action, and a lower risk of major bleeding, especially intracranial. Although evidence on the use of DOACs in unusual-site venous thrombosis (USVT) is limited, their use in such cases is becoming increasingly common. This narrative review examines the evidence derived from randomized controlled

APA, Harvard, Vancouver, ISO, and other styles

44

Radtke, H., A. Jainz, F. P. Schmidt, and H. Kiesewetter. "Protein-Z-Mangel bei ungeklärter Neigung zu Thrombosen, Blutungen oder Aborten." Hämostaseologie 32, S 01 (2012): S95—S97. http://dx.doi.org/10.1055/s-0037-1619785.

Full text

Abstract:

SummaryA protein Z deficiency is presumably related with a threefold risk of venous and arterial thrombosis. Mucosal bleedings and post-operative haematomas can occur more frequently. This is seen in an increased in vivo bleeding time without other plasmatic coagulation disorders or thrombopathies. Pregnancy complications, especially abortions before the 15th week of gestation, are described as well. Patients, methods: Since May 2011 the plasmatic concentration of protein Z has been tested in 684 patients of the Hämostaseologicum. Results: In 74 patients a protein Z deficiency has been found.

APA, Harvard, Vancouver, ISO, and other styles

45

Kopić, Vlatko, Andrijana Kopić, Mihael Mišir, and Sanjin Petrović. "Concurrent Onset of Central Retinal Vein Occlusion and Inflammation of a Large Maxillary Odontogenic Cyst: Case Report and Analysis." Reports 7, no. 3 (2024): 55. http://dx.doi.org/10.3390/reports7030055.

Full text

Abstract:

Central retinal vein occlusion typically manifests in older individuals with underlying systemic pathology, leading to a spectrum of symptoms ranging from blurred vision to complete vision loss. While odontogenic infections are recognized for causing complications affecting the eye and vision, their potential role as an etiological factor in cases of sudden vision impairment merits consideration. This article presents a case involving central retinal vein thrombosis, wherein resolution was achieved through a combination of ophthalmic therapy and the surgical removal of a concurrently existing

APA, Harvard, Vancouver, ISO, and other styles

46

Undas, Anetta. "Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence." BioMed Research International 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/8196256.

Full text

Abstract:

Prothrombotic fibrin clot phenotype, involving faster formation of dense meshwork composed of thinner and highly branched fibers that are relatively resistant to plasmin-induced lysis, has been reported in patients with not only myocardial infarction or stroke, but also venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT), and/or pulmonary embolism (PE). Prothrombotic fibrin clot phenotype, in particular prolonged clot lysis time, is considered a novel risk factor for VTE as well as venous thrombosis at unusual location, for example, cerebral sinus venous thrombosis, retinal v

APA, Harvard, Vancouver, ISO, and other styles

47

Usami, S., T. Abe, and Y. Hata. "Classification of the Venous Route of Carotid Cavernous Sinus Fistula." Interventional Neuroradiology 3, no. 2_suppl (1997): 93–96. http://dx.doi.org/10.1177/15910199970030s218.

Full text

Abstract:

It is important to investigate the venous routes in and around the carotid cavernous sinus before endovascular interventional treatment to avoid complications such as glaucoma and central retinal vein thrombosis. This paper classifies the anatomical features of the cavernous sinus and its venous routes and discusses four successfully treated cases.

APA, Harvard, Vancouver, ISO, and other styles

48

Kolenko, O. V., N. V. Pomytkina, E. L. Sorokin, and Ya E. Pashentsev. "Prognostic algorithm for risk assessment of retinal vein occlusion under geomagnetic perturbations." Pacific Medical Journal, no. 3 (November 1, 2024): 29–33. http://dx.doi.org/10.34215/1609-1175-2024-3-29-33.

Full text

Abstract:

Aim. To develop a screening and prognostic algorithm for assessing the risk of retinal vein occlusion in patients with arterial hypertension under the conditions of geomagnetic disturbances. Material and methods. In total, 1512 patients with arterial hypertension of 1–4 stages were examined. Within the period of three years, 391 patients developed retinal venous occlusions. The parameters of systemic and regional hemodynamics in these patients, as well as ocular microcirculatory function, were compared both in a magnetically calm environment and during geomagnetic disturbances. To simulate the

APA, Harvard, Vancouver, ISO, and other styles

49

Kolenko, O. V., N. V. Pomytkina, E. L. Sorokin, and Ya E. Pashentsev. "Development of a prognostic algorithm for risk of retinal vein occlusions under geomagnetic perturbations." Pacific Medical Journal, no. 3 (September 22, 2023): 84–88. http://dx.doi.org/10.34215/1609-1175-2023-3-84-88.

Full text

Abstract:

Aim. To develop a screening and prognostic algorithm for the risk of retinal vein occlusion in geomagnetic disturbances in patients with arterial hypertension.Materials and methods. In total, 1512 patients with arterial hypertension of 1–4 stages were included in the study. Within three years, 391 patients developed retinal venous occlusions. A comparative study of the parameters of systemic and regional hemodynamics, microcirculatory parameters of the eyes of these patients was carried out both in a magnetically calm environment and during geomagnetic disturbances. To simulate the response of

APA, Harvard, Vancouver, ISO, and other styles

50

Bick, Rodger L. "Sticky Platelet Syndrome: A Common Cause of Unexplained Arterial and Venous Thrombosis." Clinical and Applied Thrombosis/Hemostasis 4, no. 2 (1998): 77–81. http://dx.doi.org/10.1177/107602969800400201.

Full text

Abstract:

Sticky platelet syndrome (SPS) was first described in 1983. However, not until 1995 did the prevalence of SPS receive significant recognition in the medical literature. In 1995 we began to routinely add an SPS evaluation to patients re ferred for assessment for causation of arterial and venous thromboses to a large thrombosis hemostasis referral center. The results of our first 2-year experience suggest SPS to be a common cause of arterial and venous thromboses. With respect to otherwise unexplained venous thrombosis, the prevalence of SPS approximates that of activated protein C resistance (A

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!